Nutritional compositions containing magnesium threonate and uses thereof

US9301966B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9301966-B2
Application numberUS-201313739813-A
CountryUS
Kind codeB2
Filing dateJan 11, 2013
Priority dateJan 11, 2013
Publication dateApr 5, 2016
Grant dateApr 5, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to nutritional composition(s) comprising a carbohydrate source, a protein source, a fat source and magnesium threonate. Magnesium threonate may provide neurological health benefits when consumed. The disclosure further relates to methods of promoting neurological health by providing a nutritional composition comprising magnesium threonate. Additionally, the disclosure relates to methods of promoting GI tolerance in a pediatric subject by providing a nutritional composition comprising magnesium threonate.

First claim

Opening claim text (preview).

What is claimed is: 1. A nutritional composition comprising per 100 kcal: (i) between about 6 g and about 22 g of a carbohydrate source, (ii) between about 1 g and about 7 g of a protein source, (iii) between about 1 g and about 10.3 g of a fat source, and (iv) about 4.9 mg/100 kcal to about 45 mg/100 kcal of magnesium threonate. 2. The nutritional composition of claim 1 , further comprising a prebiotic. 3. The nutritional composition of claim 2 , wherein the prebiotic is selected from the group consisting of polydextrose and galacto-oligosaccharide. 4. The nutritional composition of claim 1 , further comprising DHA from about 5 mg to about 75 mg. 5. The nutritional composition of claim 1 , further comprising a probiotic from about 1×10 4 cfu to about 1.5×10 10 cfu. 6. The nutritional composition of claim 1 , wherein the nutritional composition is an infant formula. 7. A method of promoting GI tolerance in a pediatric subject by providing a nutritional composition comprising between about 6 g and about 22 g of a carbohydrate source, between about 1 g and about 7 g of a protein source, between about 1 g and about 10.3 g of a fat source, and between about 4.9 mg and about 45 mg of magnesium threonate per 100 kcal of nutritional composition to a pediatric subject, wherein the occurrence of oxidative neuronal cell death is reduced. 8. The method of claim 7 , wherein the nutritional composition comprises per 100 kcal: (i) between about 6 g and about 22 g of a carbohydrate source; (ii) between about 1 g and about 7 g of a protein source; (iii) between about 1 g and about 10.3 g of a fat source; (iv) between about 0.1 mg and about 1 mg of polydextrose; and (v) between about 0.1 mg and about 1 mg of galacto-oligosaccharide. 9. The method of claim 7 , wherein the nutritional composition comprises magnesium threonate from about 6 mg/100 kcal to about 26 mg/100 kcal. 10. The method of claim 7 , wherein the nutritional composition comprises magnesium threonate from about 15 mg/100 kcal to about 25 mg/100 kcal. 11. The method of claim 7 , wherein the nutritional composition further comprises DHA. 12. The method of claim 7 , wherein the nutritional composition is an infant formula. 13. A method of promoting neurological health in a pediatric subject by providing to a pediatric subject a nutritional composition comprising between about 6 g and about 22 g of a carbohydrate source, between about 1 g and about 7 g of a protein source, between about 1 g and about 10.3 g of a fat source, and between about 4.9 mg and about 45 mg magnesium threonate per 100 kcal, wherein the occurrence of oxidative neuronal cell death is reduced. 14. The method of claim 13 , wherein the nutritional composition comprises magnesium threonate from about 6 mg/100 kcal to about 26 mg/100 kcal. 15. The method of claim 13 , wherein the nutritional composition comprises magnesium threonate from about 15 mg/100 kcal to about 25 mg/100 kcal. 16. The method of claim 13 , wherein the nutritional composition further comprises DHA. 17. The method of claim 13 , wherein the nutritional composition is an infant formula.

Assignees

Inventors

Classifications

  • having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids · CPC title

  • Milk; Whey; Colostrum · CPC title

  • having two or more hydroxy groups, e.g. gluconic acid · CPC title

  • Inorganic salts, minerals or trace elements · CPC title

  • having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9301966B2 cover?
The present disclosure relates to nutritional composition(s) comprising a carbohydrate source, a protein source, a fat source and magnesium threonate. Magnesium threonate may provide neurological health benefits when consumed. The disclosure further relates to methods of promoting neurological health by providing a nutritional composition comprising magnesium threonate. Additionally, the disclo…
Who is the assignee on this patent?
Mead Johnson Nutrition Co
What technology area does this patent fall under?
Primary CPC classification A61K31/70. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).